Neuroblastoma in iran: An experience of 32 years at a referral childrens hospital

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2739-2742

  Mehdiabadi, Gholamreza Bahoush ^a,b   Arab, Elaheh ^b   Rafsanjani, Khadijeh Arjmandi ^a,b   Ansari, Shahla ^b   Moinzadeh, Amir Majid ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Farzan Clinical Research Institute   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADRENAL GLAND; ADRENAL GLAND NEOPLASMS; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; FEMALE; HOSPITAL; HUMAN; INFANT; IRAN; MALE; MORTALITY; NEUROBLASTOMA; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; IRAN; MALE; NEOPLASM STAGING; NEUROBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 85047687111     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2739     Document Type: Article

References (19)

1. Bernstein ML, Leclerc JM, Bunin G, et al (1992). A populationbased study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol, 10, 323-9.
2. Bhatnagar SN, Sarin YK (2012). Neuroblastoma: a review of management and outcome. Indian J Pediatrics, 79, 787-92.
3. Brodeur GM (2011). Knowing your ABCCs: novel functions of ABCC transporters. J Natl Cancer Inst, 103, 1207-8.
4. Chen QR, Song YK, Wei JS, et al (2008). An integrated crossplatform prognosis study on neuroblastoma patients. Genomics, 92, 195-203.
5. Cornero A, Acquaviva M, Fardin P, et al (2012). Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome. BMC Bioinformatics, 13, 13.
6. David L, Baker MLS, Susan L, et al (2010). Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med, 363, 1313-23.
7. Hara J (2012). Development of treatment strategies for advanced neuroblastoma. Int J Clinical Oncology, 17, 196-203.
8. Harder T, Plagemann A, Harder A (2010). Birth weight and risk of neuroblastoma:a meta-analysis. Int J Epidemiol, 39, 746-56.
9. Henderson TO, Bhatia S, Pinto N, et al (2011). Racial and ethnic disparities in risk and survival in children with neuroblastoma: a children's oncology group study. J Clin Oncol, 29, 76-82.
10. Hiyama E (2008). Neuroblastoma screening in Japan: populationbased cohort study and future aspects of screening. Ann Acad Med Singapore, 37, 88-91.
11. Lee A (2012). Neuroblastoma: the challenge remains. Singapore Med J, 53, 1-2.
12. Ries LAG, Krapcho M, Mariotto A, et al (2007). SEER cancer statistics review, 1975-2004. National Cancer Institute, 2007.
13. Schilling FH, Spix C, Berthold F, et al (2002). Neuroblastoma screening at one year of age. N Engl J Med, 346, 1047-53.
14. Stat B (2011). Neuroblastoma: five-year survival. J Natl Cancer Inst, 103, 1220.
15. Sung KW, Ahn HS, Cho B, et al (2010). Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005). J Korean Med Sci, 25, 691-7.
16. Tan C, Sabai SM, Tin AS, Quah TC, Aung L (2012), Neuroblastoma: experience from National University Health System, Singapore (1987-2008). Singapore Med J, 53, 19-25.
17. Vermeulen J, De Preter K, Naranjo A, et al (2009). Outcome Prediction of children with neuroblastoma using a multigene expression signature, a retrospective SIOPEN/COG/GPOH study. Lancet Oncol, 10, 663-71.
18. Weinstein JL, Katzenstein HM, Cohn SL (2003). Advances in the diagnosis and treatment of neuroblastoma. Oncologist, 8, 278-92.
19. Wiangnon S, Veerakul G, Nuchprayoon I, et al (2011). Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai pediatric oncology group. Asian Pac J Cancer Prev, 12, 2215-20.